AgomAb Therapeutics NV (AGMB)

Last Closing Price: 12.65 (2026-07-02)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

AgomAb Therapeutics NV (AGMB) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
--
Cost of Goods Sold
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
137.17M
0.77M
35.71M
173.90M
21.03M
1.14M
4.77M
25.80M
148.10M
115.61M
148.10M
--
Cash Flow Statement Financials
-58.54M
-37.34M
-0.38M
193.99M
97.77M
-96.22M
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--